NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation
Peng Zhang(Wuhan University), Yongwen Luo(Wuhan University)
Cited by 59
Related Papers
Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer
|European Journal of Pharmacology|2023|121
Tyrosine receptor kinase B silencing inhibits anoikis-resistance and improves anticancer efficiency of sorafenib in human renal cancer cells
|International Journal of Oncology|2016|32
ASCL1-mediated ferroptosis resistance enhances the progress of castration-resistant prostate cancer to neurosecretory prostate cancer
|Free Radical Biology and Medicine|2023|29